The EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...

The European Commission has proposed new rules aimed at strengthening the security of supply and availability of critical ...

The drug shortages are the result of manufacturing problems, increased demand, and other issues. View on euronews ...

A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's ...

The Critical Medicines Act is the EU’s attempt to tackle manufacturing dependencies on India and China. Europe has a plan to ...

Donald Trump's return to the White House and his announcement of future 25% tariffs on various sectors, including the pharmaceutical industry, prompted the Commission to revive the concept of ...

EU health ministers want to fund drug shortages plans with cash from Europe’s new defense strategy, they outline in an open ...

A coalition of health ministers in the EU is pushing for reduced dependency on Asia, primarily China, for essential medicines ...

The European Commission's Critical Medicines Act aims to reduce the EU's dependence on countries like China and India for ...

Critical Medicines Act gets warm reception in Ireland, industry says policy solutions must be targeted, evidence-based, and aligned with international commitments.

Otsuka Pharmaceutical Europe and Lundbeck have announced that the European Commission has approved Rxulti (brexpiprazole) for ...